Back to Rare Disease
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT05581550

NCT05581550
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You have been diagnosed with nasopharyngeal cancer (cancer at the back of the nose/throat) that is advanced, has spread, or has come back, and you are already scheduled to have an FDG PET scan as part of your care.
  • You are eligible even if you have previously had a Ga-68 DOTATATE scan (a specific type of imaging scan) before, as repeat scans are allowed.
  • Your cancer has been confirmed through a tissue biopsy or lab test.
  • You are 21 years of age or older.

Who may not be able to join:

  • You are under 21 years of age.
  • You are currently pregnant or breastfeeding.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
National Cancer Centre, Singapore
Registry
clinicaltrials_gov
Start date
29 June 2020
Est. completion
17 July 2025

Where this trial is recruiting

🇸🇬 Singapore

Primary endpoints

Amount of tracer uptake in the tumour lesions of NPC patients

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov